In January 2024, Matisse reported positive topline results from the HistoSeps trial, which was designed to evaluate the ...

Geleen, November 13th, 2025.Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, ...

Step inside the lounge at Evolved Science and you’ll find a cocktail menu unlike any you’ve ever seen. The ritzy Manhattan medical office — which says it serves high-powered clients and celebrities — ...

Unapproved peptide drugs have become a trendy new approach to building muscle, smoothing wrinkles and trying to live longer.

An IV infusion clinic in Cullman has been court ordered to temporarily close its doors after being accused of administering ...

Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...

New York:, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The global Intravenous Infusion Pumps Market was valued at US$ 5.2 Bn in 2021 and is expected to reach US$ 13.2 Bn by 2032, finds Persistence Market ...

The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody commonly used in standard regimens for HER2-positive breast cancer. FDA ...

Here are five examples of wellness trends that borrow from mainstream medicine. Ozone (O₃) is a form of oxygen. Ordinary ...